Search Results for

stroke

301-400 of 2803 Results
Sort by Relevance , Date , Title

afp20110615p1403.pdf

...tia.1 Like other types of dementia, it is characterized by progressive memory loss and cognitive decline. Alzheimer disease is usually diagnosed in persons older than 65 years, and its prevalence increases every decade thereafter. Nearly one-half of Ameri- cans 85 years and older...

American Family Physician

https://www.aafp.org/afp/2011/0615/afp20110615p1403.pdf

afp20120115p139.pdf

...associated with poorer outcomes in patients with a variety of medical con- ditions, such as coronary artery disease, diabetes mellitus, and stroke.8-10 Treatment of depression may reduce mortality from these conditions, as well as help prevent suicide.11-13 Therefore, accurately...

American Family Physician

https://www.aafp.org/afp/2012/0115/afp20120115p139.pdf

afp20120915p521-s1.pdf

...is a transient ischemic attack (TIA)? A transient ischemic attack, or TIA, happens when a blood vessel called an artery becomes blocked. This causes less blood to get to your brain. It is sometimes called a mini stroke. The difference between TIA and stroke is that in TIA, the...

American Family Physician

https://www.aafp.org/afp/2012/0915/afp20120915p521-s1.pdf

afp20120915p521.pdf

...Transient Ischemic Attack: Part I. Diagnosis and Evaluation B. BRENT SIMMONS, MD; BARBARA CIRIGNANO, MD; and ANNETTE B. GADEGBEKU, MD Drexel University College of Medicine, Philadelphia, Pennsylvania O ver the past 10 years, transient ischemic attack (TIA) has been redefined...

American Family Physician

https://www.aafp.org/afp/2012/0915/afp20120915p521.pdf

afp20130215p267-s1.pdf

...National Institute of Neurological Disorders and Stroke Website: http://www.ninds.nih.gov/disorders/ parkinsons_disease/parkinsons_disease.htm The Michael J. Fox Foundation for Parkinson’s Research Website: http://www.michaeljfox.org/ February 2013 Parkinson Disease:...

American Family Physician

https://www.aafp.org/afp/2013/0215/afp20130215p267-s1.pdf

afp20130301p337.pdf

...DKA include hypokalemia, hypoglycemia, acute renal failure, and shock. Less com­ mon problems can include rhabdomyolysis,41 throm­ bosis and stroke,42 pneumomediastinum,43 prolonged corrected QT interval,44 pulmonary edema,45 and mem­ ory loss with decreased cognitive function in...

American Family Physician

https://www.aafp.org/afp/2013/0301/afp20130301p337.pdf

afp20130415p556.pdf

...used for the prevention and treatment of dis- orders such as systemic embolism associated with atrial fibrillation, stroke, and venous thromboembolism (VTE). LMWH allows for the initiation of anticoagulation therapy on an outpatient basis. After decades during which warfarin was...

American Family Physician

https://www.aafp.org/afp/2013/0415/afp20130415p556.pdf

afp20130515p682.pdf

...Use of illicit drugs, including cocaine and metham- phetamine, can increase the risk of intracranial bleeding or stroke. Prescription or over-the-counter medications such as aspirin, other nonsteroidal anti-inflammatory drugs, anticoagulants, and glucocorticoids increase the risk of...

American Family Physician

https://www.aafp.org/afp/2013/0515/afp20130515p682.pdf

afp20130601p796.pdf

...exists. Patients in the aspirin group had a lower rate of major vascular events, defined as the composite of VTE, myocardial infarction, stroke, or cardiovascular death (5.2% vs. 8% per year; number needed to treat [NNT] = 36; P = .01). In addition, there was no significant increase...

American Family Physician

https://www.aafp.org/afp/2013/0601/afp20130601p796.pdf

afp20130601p796a.pdf

...exists. Patients in the aspirin group had a lower rate of major vascular events, defined as the composite of VTE, myocardial infarction, stroke, or cardiovascular death (5.2% vs. 8% per year; number needed to treat [NNT] = 36; P = .01). In addition, there was no significant increase...

American Family Physician

https://www.aafp.org/afp/2013/0601/afp20130601p796a.pdf

afp20130601p799.pdf

...exists. Patients in the aspirin group had a lower rate of major vascular events, defined as the composite of VTE, myocardial infarction, stroke, or cardiovascular death (5.2% vs. 8% per year; number needed to treat [NNT] = 36; P = .01). In addition, there was no significant increase...

American Family Physician

https://www.aafp.org/afp/2013/0601/afp20130601p799.pdf

afp20130615od1.pdf

...initiative sponsored by the U.S. Department of Health and Human Services that aims to decrease the number of heart attacks and strokes by 1 million over the next five years. It emphasizes the use of effective clinical preventive services combined with multifaceted policy inter-...

American Family Physician

https://www.aafp.org/afp/2013/0615/afp20130615od1.pdf

afp20130701p20.pdf

...Evidence-Based Answer Pharmacologic treatment of mild hypertension for up to five years does not reduce coronary events, stroke, or mortality compared with placebo. (Strength of Recom- mendation: B, based on inconsistent or limited-quality patient-oriented evidence.) Practice...

American Family Physician

https://www.aafp.org/afp/2013/0701/afp20130701p20.pdf

afp20130701p21.pdf

...Evidence-Based Answer Pharmacologic treatment of mild hypertension for up to five years does not reduce coronary events, stroke, or mortality compared with placebo. (Strength of Recom- mendation: B, based on inconsistent or limited-quality patient-oriented evidence.) Practice...

American Family Physician

https://www.aafp.org/afp/2013/0701/afp20130701p21.pdf

afp20130701p61.pdf

...Endovascular Therapies Do Not Improve Outcomes in Acute Stroke Clinical Question Does adding endovascular procedures to intravenous tissue plasminogen activator (t-PA) improve outcomes for patients with stroke? Bottom Line Endovascular therapies (local delivery of t-PA,...

American Family Physician

https://www.aafp.org/afp/2013/0701/afp20130701p61.pdf

afp20130801p164.pdf

...blood cells for arbitrary hemoglobin or hematocrit thresholds and in the absence of symptoms or active coronary disease, heart failure, or stroke.7 AABB guideline Don’t do workup for clotting disorder (order hypercoagulable testing) for patients who develop first episode of...

American Family Physician

https://www.aafp.org/afp/2013/0801/afp20130801p164.pdf

afp20130801p201.pdf

...diet screener, the Mediterranean diet groups had higher scores. The primary outcome was a combined end point of myocardial infarction, stroke, and cardiovascular death. This end point was less likely for both of the Mediterranean diet groups than for the low-fat diet con- trol...

American Family Physician

https://www.aafp.org/afp/2013/0801/afp20130801p201.pdf

afp20130815p231.pdf

...daytime sleepiness, obesity, treatment- refractory hypertension, need for bariatric surgery, atrial fibrillation, congestive heart failure, stroke, nocturnal cardiac dysrhythmias, type 2 diabetes mellitus, and pulmonary hypertension. If OSA is suspected, a referral for...

American Family Physician

https://www.aafp.org/afp/2013/0815/afp20130815p231.pdf

afp20130815p269.pdf

...Active or recent (within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction) Liver dysfunction or disease Known thrombophilic disorders (e.g., protein C, protein S, antithrombin deficiency) Known hypersensitivity to any of the ingredients in...

American Family Physician

https://www.aafp.org/afp/2013/0815/afp20130815p269.pdf

afp20130901p333.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p333.pdf

afp20130901p333a.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p333a.pdf

afp20130901p334.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p334.pdf

afp20130901p337.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p337.pdf

afp20131115p676-s1.pdf

...How is GCA treated? GCA requires higher doses of steroids. This will help lower your risk of going blind, having a stroke, or other problems. Your doctor may start you on steroids even before he or she is sure you have GCA. Symptoms improve quickly over a few days, but sometimes,...

American Family Physician

https://www.aafp.org/afp/2013/1115/afp20131115p676-s1.pdf

afp20131215p821.pdf

...is more effective than clopido- grel in the combined outcome of prevent- ing death from vascular causes, myocardial infarction, and stroke over the course of one year (9.8% vs. 11.7%; number needed to treat = 60; 95% confidence interval, 40 to 126).1 All-cause mortality was also...

American Family Physician

https://www.aafp.org/afp/2013/1215/afp20131215p821.pdf

afp20140201p224.pdf

...infarction risk, or stroke risk? Bottom Line Population-based screening for heart dis- ease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk. (Level of Evi- dence = 1b)...

American Family Physician

https://www.aafp.org/afp/2014/0201/afp20140201p224.pdf

afp20140201p224a.pdf

...infarction risk, or stroke risk? Bottom Line Population-based screening for heart dis- ease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk. (Level of Evi- dence = 1b)...

American Family Physician

https://www.aafp.org/afp/2014/0201/afp20140201p224a.pdf

afp20140201p226.pdf

...infarction risk, or stroke risk? Bottom Line Population-based screening for heart dis- ease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk. (Level of Evi- dence = 1b)...

American Family Physician

https://www.aafp.org/afp/2014/0201/afp20140201p226.pdf

afp20140401p574.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p574.pdf

afp20140401p574a.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p574a.pdf

afp20140401p576.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p576.pdf

afp20140401p578.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p578.pdf

afp20140615p936.pdf

...recent study. These complications include the incidence of lower-extremity amputation, end-stage renal disease, acute myocardial infarction, stroke, and deaths from hyperglycemic crisis. According to CDC researchers, possible reasons for the decline include an increased emphasis on...

American Family Physician

https://www.aafp.org/afp/2014/0615/afp20140615p936.pdf

afp20140815od2.pdf

...of hypertension and stroke. Diclofenac does not increase the risk of hypertension, but does increase the risk of stroke. Naproxen (Naprosyn) does not increase the risk of hypertension or stroke. Celecoxib (Celebrex) does not increase the risk of hypertension or stroke. Evidence...

American Family Physician

https://www.aafp.org/afp/2014/0815/afp20140815od2.pdf

afp20140901p326.pdf

...[CI], 2% to 22%), major cardiovascular events by 14% (95% CI, 5% to 33%), and heart failure by 19% (95% CI, 7% to 29%), and did not decrease stroke risk compared with placebo or other treatments. ARBs did not affect any of these outcomes other than heart failure (30% decrease; 95%...

American Family Physician

https://www.aafp.org/afp/2014/0901/afp20140901p326.pdf

afp20140901p326a.pdf

...[CI], 2% to 22%), major cardiovascular events by 14% (95% CI, 5% to 33%), and heart failure by 19% (95% CI, 7% to 29%), and did not decrease stroke risk compared with placebo or other treatments. ARBs did not affect any of these outcomes other than heart failure (30% decrease; 95%...

American Family Physician

https://www.aafp.org/afp/2014/0901/afp20140901p326a.pdf

afp20140901p331.pdf

...[CI], 2% to 22%), major cardiovascular events by 14% (95% CI, 5% to 33%), and heart failure by 19% (95% CI, 7% to 29%), and did not decrease stroke risk compared with placebo or other treatments. ARBs did not affect any of these outcomes other than heart failure (30% decrease; 95%...

American Family Physician

https://www.aafp.org/afp/2014/0901/afp20140901p331.pdf

afp20141015p579.pdf

...may be limited by the small sample size, which prevents the ability to detect differences in incidence of diabetes complications, including stroke and myocardial infarction. Study design: Randomized controlled trial (nonblinded) Funding source: Industry plus government...

American Family Physician

https://www.aafp.org/afp/2014/1015/afp20141015p579.pdf

afp20150201p172-s1.pdf

...is it important to treat high blood pressure? Treatment is important because having high blood pressure increases your risk of heart attack, stroke, and heart failure. How is it detected? Your doctor can measure your blood pressure with a blood pressure cuff that goes around your...

American Family Physician

https://www.aafp.org/afp/2015/0201/afp20150201p172-s1.pdf

afp20150401p434.pdf

March 1, 2015 Editorials

American Family Physician

https://www.aafp.org/afp/2015/0401/afp20150401p434.pdf

afp20150501p625-s1.pdf

...if you smoke, talk with your doctor about birth control that has estrogen in it. These conditions may increase your risk of blood clots and stroke. Condoms are the only birth control method that decreases your risk of getting a sexually transmitted infection. Condoms can be used...

American Family Physician

https://www.aafp.org/afp/2015/0501/afp20150501p625-s1.pdf

afp20151001p556.pdf

...pulmo- nary disease, congestive heart failure, hypertension, cor- onary artery disease, or mood disorders. Patients with a history of stroke also will be included in the test model. According to CMS, the model will test the hypoth- esis that if Medicare Advantage plans offer...

American Family Physician

https://www.aafp.org/afp/2015/1001/afp20151001p556.pdf

afp20160201p177.pdf

February 1, 2016 Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/0201/afp20160201p177.pdf

afp20160201p178.pdf

February 1, 2016 Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/0201/afp20160201p178.pdf

afp20160301p411.pdf

...was 63 years, 71% were men, and 5% were black. This was a very high-risk group: 75% had coronary artery disease, 23% had a previous stroke, 20% had peripheral arterial disease, and 25% had a coronary artery bypass graft. The other hypoglycemic medications used by patients included...

American Family Physician

https://www.aafp.org/afp/2016/0301/afp20160301p411.pdf

afp20160501p738.pdf

...(A) Recommend aspirin use in women 55 to 79 years of age for reduction in ischemic stroke if benefit outweighs risk (I) IETRFOA aspirin for primary prevention of cardiovascular risk reduction in individuals 80 years and older (D) Recommend against use of aspirin for CVD...

American Family Physician

https://www.aafp.org/afp/2016/0501/afp20160501p738.pdf

afp20160615p1032.pdf

...Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality Clinical Question Does intensive lowering of blood pressure (BP) improve the lives of patients with hypertension? Bottom Line Patients with hypertension who are...

American Family Physician

https://www.aafp.org/afp/2016/0615/afp20160615p1032.pdf

afp20160615p1032a.pdf

...Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality Clinical Question Does intensive lowering of blood pressure (BP) improve the lives of patients with hypertension? Bottom Line Patients with hypertension who are...

American Family Physician

https://www.aafp.org/afp/2016/0615/afp20160615p1032a.pdf

afp20160615p1036.pdf

...Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality Clinical Question Does intensive lowering of blood pressure (BP) improve the lives of patients with hypertension? Bottom Line Patients with hypertension who are...

American Family Physician

https://www.aafp.org/afp/2016/0615/afp20160615p1036.pdf

afp20160901od1.pdf

September 1, 2016: Medicine by the Numbers

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901od1.pdf

afp20160901p384.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p384.pdf

afp20160901p384a.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p384a.pdf

afp20160901p386.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p386.pdf

afp20160901p387.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p387.pdf

afp20161101p691.pdf

November 1, 2016: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/1101/afp20161101p691.pdf

afp20161101p692.pdf

November 1, 2016: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/1101/afp20161101p692.pdf

afp20161115p820-s1.pdf

...to the nerves and blood vessels in the penis. This allows the penis to fill with blood. Some medical conditions block these signals, such as strokes, spine or pelvic injuries, Parkinson disease, and multiple sclerosis. Nerve damage from diabetes or prostate surgery can also cause...

American Family Physician

https://www.aafp.org/afp/2016/1115/afp20161115p820-s1.pdf

afp20161201p880.pdf

December 1, 2016: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/1201/afp20161201p880.pdf

afp20161201p881.pdf

December 1, 2016: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/1201/afp20161201p881.pdf

afp20161215p972-s1.pdf

...National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/disorders/autism/detail_ autism.htm National Library of Medicine https://medlineplus.gov/autismspectrumdisorder.html December 2016 Autism Spectrum Disorder (continued) Notes: _GoBack...

American Family Physician

https://www.aafp.org/afp/2016/1215/afp20161215p972-s1.pdf

afp20170215p222.pdf

February 15, 2017: Editorials

American Family Physician

https://www.aafp.org/afp/2017/0215/afp20170215p222.pdf

afp20170301p303-s1.pdf

...National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/disorders/syncope/ syncope.htm National Library of Medicine https://www.nlm.nih.gov/medlineplus/fainting.html March 2017...

American Family Physician

https://www.aafp.org/afp/2017/0301/afp20170301p303-s1.pdf

afp20170315od1.pdf

...time, intensive glucose lowering did not increase or decrease the primary composite outcome of nonfatal myocardial infarction, nonfatal stroke, CV death, death from any other cause, or overall mortality. The increased CV mortality rate seen with intensive control during the active...

American Family Physician

https://www.aafp.org/afp/2017/0315/afp20170315od1.pdf

afp20170315od2.pdf

...time, intensive glucose lowering did not increase or decrease the primary composite outcome of nonfatal myocardial infarction, nonfatal stroke, CV death, death from any other cause, or overall mortality. The increased CV mortality rate seen with intensive control during the active...

American Family Physician

https://www.aafp.org/afp/2017/0315/afp20170315od2.pdf

afp20170315p396.pdf

...Bottom Line Semaglutide significantly reduced the composite out- come of CV death, nonfatal myocardial infarction, and nonfatal stroke (number needed to treat [NNT] = 43 over 2.1 years). It was generally well tolerated, and it reduced body weight by approximately 6.4 to 9.5 lb (2.9...

American Family Physician

https://www.aafp.org/afp/2017/0315/afp20170315p396.pdf

afp20170401p455.pdf

...a recent myocardial infarction, 17% had a previous PCI, and 16% had renal insuffi- ciency. The primary end point was a composite of death, stroke, or myocardial infarction at three years. Groups were similar at the start of the study, and analysis was by intention to treat. This...

American Family Physician

https://www.aafp.org/afp/2017/0401/afp20170401p455.pdf

afp20170401p455a.pdf

...a recent myocardial infarction, 17% had a previous PCI, and 16% had renal insuffi- ciency. The primary end point was a composite of death, stroke, or myocardial infarction at three years. Groups were similar at the start of the study, and analysis was by intention to treat. This...

American Family Physician

https://www.aafp.org/afp/2017/0401/afp20170401p455a.pdf

afp20170401p456.pdf

...a recent myocardial infarction, 17% had a previous PCI, and 16% had renal insuffi- ciency. The primary end point was a composite of death, stroke, or myocardial infarction at three years. Groups were similar at the start of the study, and analysis was by intention to treat. This...

American Family Physician

https://www.aafp.org/afp/2017/0401/afp20170401p456.pdf

afp20170401p457.pdf

...a recent myocardial infarction, 17% had a previous PCI, and 16% had renal insuffi- ciency. The primary end point was a composite of death, stroke, or myocardial infarction at three years. Groups were similar at the start of the study, and analysis was by intention to treat. This...

American Family Physician

https://www.aafp.org/afp/2017/0401/afp20170401p457.pdf

afp20170501p580.pdf

February 15, 2017: Point-of-Care Guides

American Family Physician

https://www.aafp.org/afp/2017/0501/afp20170501p580.pdf

afp20170601p700.pdf

June 1, 2017: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2017/0601/afp20170601p700.pdf

afp20170715p128.pdf

...it does not affect all-cause mortality rates. It also does not lower the risk of cardiovascular mortality, nonfatal myocar- dial infarction, stroke, or the need for revascularization. There was no significant heterogeneity among trials. Even studies that specifically enrolled...

American Family Physician

https://www.aafp.org/afp/2017/0715/afp20170715p128.pdf

afp20170715p128a.pdf

...it does not affect all-cause mortality rates. It also does not lower the risk of cardiovascular mortality, nonfatal myocar- dial infarction, stroke, or the need for revascularization. There was no significant heterogeneity among trials. Even studies that specifically enrolled...

American Family Physician

https://www.aafp.org/afp/2017/0715/afp20170715p128a.pdf

afp20170715p129.pdf

...it does not affect all-cause mortality rates. It also does not lower the risk of cardiovascular mortality, nonfatal myocar- dial infarction, stroke, or the need for revascularization. There was no significant heterogeneity among trials. Even studies that specifically enrolled...

American Family Physician

https://www.aafp.org/afp/2017/0715/afp20170715p129.pdf

afp20170801p161-s1.pdf

...What can I do to prevent heart problems? People with HIV infection are at higher risk of heart disease and stroke. You have an even higher risk if you smoke, have high cholesterol, high blood pressure, or diabetes, or if heart attacks run in your family. You can lower your risk by...

American Family Physician

https://www.aafp.org/afp/2017/0801/afp20170801p161-s1.pdf

afp20170801p179-s1.pdf

...vaginal bleeding, problems passing urine or stool, or any change in your ability to take care of the pessary (for instance, if you have a stroke or arthritis). What are Kegel exercises? Kegels (KEE-guls) are exercises that strengthen the muscles of the pelvis. To do a Kegel, you...

American Family Physician

https://www.aafp.org/afp/2017/0801/afp20170801p179-s1.pdf

afp20171001p428.pdf

October 1, 2017: Editorials

American Family Physician

https://www.aafp.org/afp/2017/1001/afp20171001p428.pdf

afp20171001p470.pdf

...statin therapy for slightly more than two years will prevent one myocardial infarction (MI) for every 83 persons treated and prevent one stroke for every 250 persons treated. At the current cost of the drug in the United States, that amounts to approximately $2.5 mil- lion per...

American Family Physician

https://www.aafp.org/afp/2017/1001/afp20171001p470.pdf

afp20171115p668.pdf

November 1, 2017: AHRQ

American Family Physician

https://www.aafp.org/afp/2017/1115/afp20171115p668.pdf

afp20171215p776.pdf

...3. Townsend RR. Stroke in chronic kidney disease: prevention and man- agement. Clin J Am Soc Nephrol. 2008; 3(suppl 1): S11-S16. 4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney dis- ease and the risks of death, cardiovascular events, and hospitalization...

American Family Physician

https://www.aafp.org/afp/2017/1215/afp20171215p776.pdf

afp20180101p29.pdf

...heart failure, depression, emphysema, falls, hypertension, incontinence, stage 3 or worse chronic kidney disease, myocardial infarction, and stroke. A total of at least 3 conditions is considered multiple, but many patients may have 5 or more. ‡-The presence of a single end-stage...

American Family Physician

https://www.aafp.org/afp/2018/0101/afp20180101p29.pdf

afp20180115od1.pdf

...It is the second leading cause of maternal mortality worldwide 7,8 and may also lead to other serious maternal complications, including stroke, eclampsia, and organ fail- ure. Adverse perinatal outcomes for the fetus and newborn include intrauterine growth restriction, low birth...

American Family Physician

https://www.aafp.org/afp/2018/0115/afp20180115od1.pdf

afp20180201od1.pdf

...Efficacy End Points: Reduction in incidence of mortality, stroke, coronary heart disease, or total cardiovascular disease Harm End Points: Mortality, stroke, coronary heart disease, cardiovascular events, or nonadherence due to adverse effects Narrative: Hypertension is one of...

American Family Physician

https://www.aafp.org/afp/2018/0201/afp20180201od1.pdf

afp20180215p243.pdf

...Cause of stroke; can be spontaneous or follow minor trauma or sudden neck movement; unilateral headache or face pain; ipsilateral Horner syndrome Cervical spondylosis Worse with neck movement; posterior distribution; pain is neuralgic in character and sometimes referred to vertex...

American Family Physician

https://www.aafp.org/afp/2018/0215/afp20180215p243.pdf

afp20180315p372.pdf

...composite major CVD events (6.2% vs. 7.3%; relative risk = 0.84; num- ber needed to treat = 91) and the combination of fatal and nonfatal stroke (2.4% vs. 2.9%; relative risk = 0.82; number needed to treat = 200) were significantly decreased when the lower cutoff was used. On the...

American Family Physician

https://www.aafp.org/afp/2018/0315/afp20180315p372.pdf

afp20180315p376.pdf

...25% of men and 16% of women 60 to 79 years of age have diagnosed or undiagnosed CAD, or a cardiovascular disease (CVD) equivalent such as stroke or peripheral arterial disease.3 CAD is one of the leading causes of mortality in the United States, accounting for 31% of all deaths in...

American Family Physician

https://www.aafp.org/afp/2018/0315/afp20180315p376.pdf

afp20180315p398.pdf

...accounts for 10% of cases, but it commonly presents as a mixed dementia with Alzheimer disease. Lewy body dementia, Parkinson-related demen- tia, normal-pressure hydrocephalus, and frontotemporal dementia represent most of the remaining cases. Fronto- temporal dementia, while...

American Family Physician

https://www.aafp.org/afp/2018/0315/afp20180315p398.pdf

afp20180315p413.pdf

...Acute ischemic stroke < 185/110 before adminis- tration of intravenous tissue plasminogen activator; < 180/105 for at least 24 hours after initiating drug therapy Chronic kidney disease < 130/80 Diabetes mellitus < 130/80 Heart failure With preserved ejec- tion fraction...

American Family Physician

https://www.aafp.org/afp/2018/0315/afp20180315p413.pdf

afp20180401od2.pdf

...H, Ballard C, Aarsland D, Selbæk G. Short- and long-term mortality risk associ- ated with the use of antipsychotics among 26,940 demen- tia outpatients: a population-based study. Am J Geriatr Psychiatry. 2014;22(4):321-331. ■

American Family Physician

https://www.aafp.org/afp/2018/0401/afp20180401od2.pdf

afp20180401p436.pdf

...Evidence-Based Answer Prescription niacin (nicotinic acid, vitamin B3) does not reduce myocardial infarctions, strokes, or overall mortality when used for primary or secondary prevention.1 (Strength of Recommen- dation: A, based on consistent, good-quality patient-oriented...

American Family Physician

https://www.aafp.org/afp/2018/0401/afp20180401p436.pdf

afp20180401p437.pdf

...Evidence-Based Answer Prescription niacin (nicotinic acid, vitamin B3) does not reduce myocardial infarctions, strokes, or overall mortality when used for primary or secondary prevention.1 (Strength of Recommen- dation: A, based on consistent, good-quality patient-oriented...

American Family Physician

https://www.aafp.org/afp/2018/0401/afp20180401p437.pdf

afp20180401p478.pdf

...heart failure; hypertension; age 75 years or older; diabetes mellitus; previous stroke, transient ischemic attack, or throm- boembolism [doubled]) score. Abnormal findings on ECG and a lower glomerular filtration rate are also risk factors. Although it has not been shown to be...

American Family Physician

https://www.aafp.org/afp/2018/0401/afp20180401p478.pdf

afp20180415od1.pdf

...is expected to live another 30 years. The prevalence and incidence of most chronic con- ditions, such as coronary heart disease, dementia, stroke, fractures, and breast cancer, increase with age; however, the excess risk for these conditions that can be attributed to menopause alone...

American Family Physician

https://www.aafp.org/afp/2018/0415/afp20180415od1.pdf

afp20180415p496.pdf

...(anti- factor Xa activity) data.2,3 The dosing the authors list in Table 1 is most similar to dosing guidelines for reduction of the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. However, that recommendation requires an adjustment to the...

American Family Physician

https://www.aafp.org/afp/2018/0415/afp20180415p496.pdf

afp20180415p497.pdf

...(anti- factor Xa activity) data.2,3 The dosing the authors list in Table 1 is most similar to dosing guidelines for reduction of the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. However, that recommendation requires an adjustment to the...

American Family Physician

https://www.aafp.org/afp/2018/0415/afp20180415p497.pdf

afp20180415p529.pdf

...Edoxaban (Savaysa) is a once-daily, oral anticoagulant used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also labeled for the treatment of deep venous thrombosis and pulmonary embolism fol- lowing initial parenteral...

American Family Physician

https://www.aafp.org/afp/2018/0415/afp20180415p529.pdf

afp20180415p533.pdf

...Oxygen Supplementation After Acute Stroke Does Not Improve Functional Outcomes Clinical Question Does routine low-dose oxygen therapy following an acute stroke improve functional outcomes? Bottom Line For nonhypoxic patients with acute stroke, rou- tine oxygen therapy for 72...

American Family Physician

https://www.aafp.org/afp/2018/0415/afp20180415p533.pdf

afp20180415p541.pdf

...Although estrogen alone has no net benefit in postmenopausal women who have had a hyster- ectomy, one potential benefit is a reduced risk of stroke. Answers 1. The correct answers are A, B, and C. Although the use of combined estrogen and progestin hormone therapy in...

American Family Physician

https://www.aafp.org/afp/2018/0415/afp20180415p541.pdf

afp20180501p562.pdf

...Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovas- cular...

American Family Physician

https://www.aafp.org/afp/2018/0501/afp20180501p562.pdf

afp20180501p581.pdf

...mostly very small, and there is no difference among them for the most important outcomes (death from any cause, cardiovascular death, and stroke). If you choose to recommend celecoxib over less expensive drugs such as naproxen or ibuprofen, prescribe the generic version, which is...

American Family Physician

https://www.aafp.org/afp/2018/0501/afp20180501p581.pdf

25 50 100 results per page